(Q45359397)

13 December 2017

title

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade (English)

1 reference

13 December 2017

1 reference

9

1 reference

13 December 2017

Joan M Sweet

3

0 references

Anthony M Joshua

object named as

Anthony M Joshua

7

0 references

author name string

Maisa Yoshimoto

1

1 reference

13 December 2017

Keyue Ding

2

1 reference

13 December 2017

Olga Ludkovski

4

1 reference

13 December 2017

Greg Trottier

5

1 reference

13 December 2017

Kyu S Song

6

1 reference

13 December 2017

Neil E Fleshner

8

1 reference

13 December 2017

Andrew J Evans

10

1 reference

13 December 2017

publication date

28 September 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

26

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

435-447

1 reference

Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Prediction of tumor heterogeneity in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Unusual subtypes of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Molecular genetics of prostate cancer: new prospects for old challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Prostate cancer as a model system for genetic diversity in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

TMPRSS2-ERG and PTEN loss in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

The role of the ETS factor erg in zebrafish vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

ETS proteins and MMPs: partners in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

PI(3)king apart PTEN's role in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

PTEN/MMAC1 mutations in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Targeting the PI3K/AKT pathway for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Biological determinants of cancer progression in men with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Evidence of independent origin of multiple tumors from patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Microdeletion and concurrent translocation associated with a complexTMPRSS2:ERG prostate cancer gene fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

Analysis of PTEN and the 10q23 region in primary prostate carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

ThePTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

Abnormalities in chromosome 17 and p53 in lung carcinoma cells detected by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

Loss of heterozygosity in the clonal evolution of flat colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

TM4: a free, open-source system for microarray data management and analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

Molecular analysis of multifocal prostate cancer lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.162

7 January 2021

10.1038/MODPATHOL.2012.162

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1028133198

0 references

1 reference